Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 936

Results For "IT"

10146 News Found

RDIF offers vaccine for adolescents aged 12-17 in India
News | December 07, 2021

RDIF offers vaccine for adolescents aged 12-17 in India

Sputnik M is a new member of the Sputnik vaccines family


Gan & Lee gets U.S. FDA clearance for novel glucagon-like peptide-1 analogue
Biotech | December 07, 2021

Gan & Lee gets U.S. FDA clearance for novel glucagon-like peptide-1 analogue

The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects


Study shows Glaxo-Vir drug works against Omicron mutations
News | December 07, 2021

Study shows Glaxo-Vir drug works against Omicron mutations

Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19


Roche develops tests to identify Omicron variant
Medical Device | December 06, 2021

Roche develops tests to identify Omicron variant

Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions


Roche to launch SARS-CoV-2 and flu A/B Rapid Antigen Test in countries accepting the CE mark
Medical Device | December 06, 2021

Roche to launch SARS-CoV-2 and flu A/B Rapid Antigen Test in countries accepting the CE mark

The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions


J&J booster after the two-dose Pfizer-BioNTech vaccine increases antibody and T-cell responses
News | December 06, 2021

J&J booster after the two-dose Pfizer-BioNTech vaccine increases antibody and T-cell responses

These results demonstrate the potential benefits of heterologous boosting (mix-and-match). The article describing these results have been posted on medRxiv


Lupin and Biomm  tie-up for pegfilgrastim in Brazil
News | December 05, 2021

Lupin and Biomm tie-up for pegfilgrastim in Brazil

Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar


Ophthalmologists converge in Chennai to discuss latest innovations
Events | December 05, 2021

Ophthalmologists converge in Chennai to discuss latest innovations

IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery


SPARC to licence Biomodifying’s IP
Biotech | December 05, 2021

SPARC to licence Biomodifying’s IP

SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP


Morpen gets U.S. FDA approval for Fexofinadine
Drug Approval | December 05, 2021

Morpen gets U.S. FDA approval for Fexofinadine

Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever